Genmab — Maj 2020
-
14:00 CET. Leading oncologists will surely post results on twitter shortly after
-
Beginning Friday, May 29 at 8:00 AM ET
Oral, Poster Discussion, and Poster Sessions, as well as track-based Clinical Science Symposia, will be available on demand.
Registrants will have exclusive access to hundreds of video and slide presentations, as well as discussant commentary for 180 days -
hvordan åbner man chat vinduet på iphone?
-
har fundet den
-
ja, men jeg skulle først trykke på "åbn chat", det var det jeg ikke kunne huske, eller tak

-
small New trial : Daratumumab, Azacitidine, and Dexamethasone for Treatment of Patients With Recurrent or Refractory Multiple Myeloma Previously Treated With Daratumumab https://www.clinicaltrials.gov/ct2/show/NCT04407442?cond=Multiple+Myeloma&sfpd_s=05%2F15%2F2020&sfpd_d=14&sel_rss=new14
-
Darvin. Jeg tror de vågner 14.05 ????
-
...it's the final countdown!

-
Måske nogen kan få lidt ud af denne slørede version...https://meetinglibrary.asco.org/record/186016/poster
-
EL - fastest googler in the west, nothing yet?
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind
-CD3xCD20) Phase 1/2 dose-escalation study on Friday May 29 at 8 AM EDT.